As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Regeneron Pharmaceuticals: Readystate Asset Management LP, GTS Securities LLC, Torno Capital LLC, Wolverine Trading LLC, Parallax Volatility Advisers L.P., Citadel Advisors LLC, Cubist Systematic Strategies LLC, Balyasny Asset Management L.P., Nomura Holdings Inc., Cresset Asset Management LLC, Verition Fund Management LLC, PEAK6 Investments LLC, Eisler Capital UK Ltd., Goldman Sachs Group Inc., Capstone Investment Advisors LLC, Allianz Asset Management GmbH, Hsbc Holdings PLC, Mendel Money Management, Wells Fargo & Company MN, UBS Group AG, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., Simplex Trading LLC, XR Securities LLC, SpiderRock Advisors LLC, Covenant Asset Management LLC, and SG Americas Securities LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.